Michael Goller

Director at Terremoto Biosciences.

Earliest Form D on file: Apr 2026

Filed Apr 22, 2026

Terremoto Biosciences

Selective AKT1 inhibitors for breast cancer and solid tumors

Biotech, South San Francisco CA

Named, Director.

$40.725M

sold of $108.6M offered

Network

At Terremoto Biosciences

6 people

James Christensen
Executive Officer, Director, signed as President
Charles Baum
Executive Officer, Director
Daniel O'Connell
Director
Grace Lu
Executive Officer
Peter Thompson
Director
Reid Huber
Director